A new study examining cholesteryl esters suggests that periods of prolonged inactivity may affect people differently depending on their age.
Psychedelics companies see FDA panel’s vote as a growth opportunity, not a roadblock
A day after a panel of advisers to the Food and Drug Administration expressed deep concerns about the use of MDMA to help treat post-traumatic